BioNTech 20 avr. 2026 Assessing BioNTech (NasdaqGS:BNTX) Valuation After Recent Share Price Momentum - simplywall.st
BioNTech 18 avr. 2026 BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
FierceBiotech 13 avr. 2026 BioNTech, SynOx plot paths to FDA as trials hit goals in competitive tumor types
BioNTech 2 avr. 2026 BioNTech telegraphs closure of Singapore vaccine facility amid efforts to 'align capacity' - Fierce Pharma
BioNTech 2 avr. 2026 Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles - Reuters
Endpoints News 14 mars 2026 Roche’s breast cancer failure; BioNTech co-founders to depart; Eli Lilly’s quest to stay on top; and more
Endpoints News 2 mars 2026 Aardvark's stock plummets on study pause; BioNTech heads to Phase 3 with DualityBio ADC
FierceBiotech 28 févr. 2026 BioNTech advances DualityBio ADC into phase 3 with half the patients of Merck-Daiichi rival
Endpoints News 9 déc. 2025 #SABCS25: BioNTech, BMS unwrap Phase 2 data for PD-L1xVEGF-A bispecific in breast cancer